Method for Predicting the Responsiveness to an Anti-TNF Alpha Antibody Treatment
AssigneeInserm (Institut National De La Sante Et De La Recherche Medicale)
InventorYannick Jacques
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for predicting the responsiveness of a patient to an anti-TNFα antibody treatment.
Claims15
A method for predicting the responsiveness of a patient to an anti-TNFα antibody treatment, said method comprising the step of measuring the level of IL-15 in a biological sample obtained from said patient, wherein a high level of IL-15 is predictive of a response to an anti-TNFα antibody treatment.
A method for treating a patient suffering from an inflammatory disease, comprising administering an effective amount of an anti-TNFα antibody to said patient, wherein said patient has a high level of IL-15.
Dependencies are inferred from the claim text.